§ Funding Round
Series C funding round for Enveda Biosciences raising $130M in November 2024
Series C funding round for Enveda Biosciences raising $130M in November 2024
| Investor | Firm Type | Partner |
|---|---|---|
Builders VC | — | — |
| Organization | — | |
Dimension Capital | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Johnson | — | — |
KinnevikLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | chris gibson | |
| Angel | henry kravis | |
| Angel | rajiv chegu | |
| Organization | — | |
pegah ebrahimiLEAD | Angel | pegah ebrahimi |
James Anderson | — | — |
| Organization | — | |
Premji Invest | — | — |
The Nature Conservancy | — | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $130M in a Series C round.
The round was announced on 11/01/24.
The round was led by Kinnevik, pegah ebrahimi.
